BioVaxys Technology is headquartered in Etobicoke, Ontario.
BioVaxys Technology disclosed revenue of 6M CAD for 2023 and 4M CAD for 2022.
BioVaxys Technology is a life science company.
146 Thirtieth Street Suite 100,
Etobicoke, Ontario
M8W 3D4
Canada,
(646) 452-7054
www.biovaxys.com
BioVaxys Technology is a clinical stage biotechnology company that is developing viral and oncology vaccine platforms, as well as immuno-diagnostics. BioVaxys Technology is based in Etobicoke, Ontario.
| Year | ≤ '20 | '21 | '22 | '23 | '24 | '25 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.2/yr) | # | - | - | - | 1 | - | - | 1 |
| Sell (0.0/yr) | # | - | - | - | - | - | - | 0 |
| 1 | ||||||||
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
